About Incline Therapeutics
Incline Therapeutics is a Healthcare company based in Redwood City (United States) founded in 2009, and was acquired by The Medicines Company in December 2012. Hospital-focused specialty pharmaceuticals are developed for acute pain management. Incline Therapeutics has raised $43.94 million across 3 funding rounds from investors including Frazier Healthcare Partners, The Medicines Company and 5AM Ventures. Its focus areas include Life Sciences, Drug Delivery, Patches and Pain Management. Its legal entity is Incline Therapeutics, Inc. Its competitors include Flexion Therapeutics, Cara Therapeutics and Eliem Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Incline Therapeutics was founded in 2009 in Redwood City, United States, as a developer of specialty pharmaceuticals targeted at hospital settings. Operations center on iontophoretic transdermal systems for opioid analgesia in postoperative care. The lead product, IONSYS, a needleless patient-controlled device, received approvals in the US and Europe but faced voluntary recall in Europe due to stability issues and was not commercialized in the US.
- Headquarters Redwood City, United States
- Stage Acquired
- SectorsHealthcare
- Website inclinethera.com
- Social LinkedIn
- Acquired by The Medicines Company (Dec 2012)
- Legal Name Incline Therapeutics, Inc.
- Total Equity Funding$43.94M (USD)
in 3 rounds
- Latest Funding Round$21.5M (USD), Series B
Sep 2011
- InvestorsFrazier Healthcare Partners
& 6 more
- Acquired byThe Medicines Company
(Dec 2012)
Funding Insights of Incline Therapeutics
Incline Therapeutics has successfully raised a total of $43.94M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $21.5 million completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $43.94M
- Total Rounds 3
- Last Round Series B β $21.5M
- First Round $440,000
(Jan 2010)
- Investors Count 6
All 3 funding rounds of Incline Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2011 | $21.5M | Series B | β | β | β |
| Jun 2010 | $22M | Series B | β | Frazier Healthcare Partners, 5AM Ventures | β |
| Jan 2010 | $440,000 | Seed | β | β | β |
7 investors in total: 7 institutional.
Investors in Incline Therapeutics
Incline Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Frazier Healthcare Partners, The Medicines Company and 5AM Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
Venture capital fund backed incubator focused on the healthcare startups | 5amventures.com | San Francisco, United States | ||
Investments are made in US life sciences and energy companies. | technologypartners.com | Palo Alto, United States | ||
Private markets investment management with strategies in equity, credit, and secondary investments. | adamsstreetpartners.com | |||
Direct secondary investments are made in private company shares. | saintscapital.com | Denver, United States | ||
Funding and expertise are provided for medical device development. | 2017 | emvllp.com | San Jose, United States | |
Markets and developing drugs in areas of acute cardiovascular care, infectious disease care and perioperative care. | 1996 | themedicinescompany.com | Parsippany Troy Hills, United States |
Investor details for Incline Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Incline Therapeutics
4 dated milestones of Incline Therapeutics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Incline Therapeutics is founded.
- Funding First funding round of $440K.
- Funding Latest funding round, Series B, of $21.5M.
- Exit Acquired by The Medicines Company.
Competitors of Incline Therapeutics
Incline Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Flexion Therapeutics, Cara Therapeutics and Eliem Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| flexiontherapeutics.com | 2007 | Woburn, United States | $62M | 692 | Developer of therapies for the treatment of musculoskeletal disorders | |
| caratherapeutics.com | 2004 | New York, United States | $51M | 79 | Developer of therapeutics for pain relief and inflammatory diseases | |
| eliemtx.com | 2018 | Boston, United States | $171.3M | 30 | Develops antibody-based treatments for autoimmune and inflammatory disorders. |
Detailed competitors of Incline Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Incline Therapeutics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Incline Therapeutics
Incline Therapeutics was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Incline Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Incline Therapeutics is a funded company, having raised a total of $43.94M across 3 funding rounds to date. The company's 1st funding round was a Seed of $440K, raised on Jan 2010.
Incline Therapeutics was founded in 2009 in Redwood City, United States, as a developer of specialty pharmaceuticals targeted at hospital settings. Operations center on iontophoretic transdermal systems for opioid analgesia in postoperative care. The lead product, IONSYS, a needleless patient-controlled device, received approvals in the US and Europe but faced voluntary recall in Europe due to stability issues and was not commercialized in the US.
Incline Therapeutics's top competitors include Flexion Therapeutics, Cara Therapeutics and Eliem Therapeutics.
Incline Therapeutics has 7 investors. Key investors include Frazier Healthcare Partners, The Medicines Company, 5AM Ventures, Technology Partners, and Adams Street Partners.
Incline Therapeutics operates through Incline Therapeutics, Inc..
Yes. Incline Therapeutics was acquired by The Medicines Company in December 2012.
